AmerisourceBergen's Industry Has High Uncertainty

13:53 EST 13 Nov 2017 | Topix

Trying to understand compounds within drugs to clinical drug trial data/process is complicated and the reason why investors should stay away from drug manufacturers unless they truly understand these unique characteristics of the industry. There are other ways to getting exposure to the health care industry and aging population tailwinds.

Original Article: AmerisourceBergen's Industry Has High Uncertainty


More From BioPortfolio on "AmerisourceBergen's Industry Has High Uncertainty"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...